Ligand validation:6CRD

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6CRD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6CRD_NAG_A_516	75%	41%	0.107	0.94	0.73	1.53	-	3	0	0	100%	0.9333
6CRD_NAG_C_514	68%	17%	0.125	0.936	0.76	2.76	-	5	1	0	100%	0.9333
6CRD_NAG_B_512	58%	20%	0.15	0.929	1.04	2.28	1	4	0	0	100%	0.9333
6CRD_NAG_E_514	54%	38%	0.146	0.911	0.74	1.68	1	2	0	0	100%	0.9333
6CRD_NAG_G_514	51%	30%	0.133	0.887	0.91	1.84	1	2	1	0	100%	0.9333
6CRD_NAG_B_513	49%	39%	0.152	0.898	0.71	1.66	-	3	1	0	100%	0.9333
6CRD_NAG_H_514	44%	34%	0.162	0.888	0.86	1.73	1	3	0	0	100%	0.9333
6CRD_NAG_F_514	36%	38%	0.163	0.856	0.91	1.5	1	4	0	0	100%	0.9333
1NCC_NAG_N_475	92%	22%	0.069	0.959	1.45	1.77	2	5	1	0	100%	0.9333
2C4L_NAG_A_1472	85%	44%	0.088	0.964	0.46	1.69	-	5	5	0	93%	0.9333
7NN9_NAG_A_476	69%	29%	0.085	0.898	1.07	1.76	-	3	0	0	100%	0.9333
1NCA_NAG_N_475	61%	39%	0.111	0.898	0.97	1.42	-	2	0	0	100%	0.9333
5NN9_NAG_A_477	61%	41%	0.093	0.879	0.87	1.39	-	3	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.